In the acute phase, METH causes an excessive release of dopamine and glutamate, resulting in transient deficits in attention and working memory (Mark et al., 2004)
More specifically, Bhagavathula and colleagues pooled efficacy outcome data in the same analysis irrespective of type of comparator (placebo or GLP-1 RA) [26]
For those in a maintenance phase after weight loss, microdosing can help preserve metabolic gains without the appetite suppression of higher doses, prioritizing sustainability , tolerability , and resilience important for long-term health optimization
Biased receptor signaling in drug discovery
In a post-Grammys interview, Jelly Roll thanked fans for believing in him from day one, well before his now-viral weight loss
Very interesting direction Dr Santosh Singh The GLP-1 space is clearly moving from just the molecule to how patients actually use it in the real world